Abstract
There are few studies on the collection and market of medicinal plants in South America and particularly in Peru. Through a review of secondary sources, information is gathered on the use and market of medicinal plants, and information is provided on the collection, collection and market of medicinal plants in the department of Cajamarca, focused on a chain of value of fresh plants (57 species) and another of dry plants (37 species), which mainly supply coastal markets. It is also reported on the collection in the first months of the COVID19 pandemic. The species come mainly from the Quechua region (2300 to 3500 masl), 51% are wild and the others are cultivated or weeds. Its main threats are mining, agricultural expansion, overgrazing, burning of natural vegetation, and over-harvesting. The monetary value of these plants is approximately US $ 804,333.64/year. In the first months of COVI19, the demand for eucalyptus, matico, chamomile and husk increased, mainly, and prices rose by more than 200%. Value chains are informal, they add minimal value to products, with the predominance of the interest of wholesale collectors.
Highlights
In Peru 80% of the population uses phytotherapy as a medicinal resource, 76% of population insured by EsSalud are willing to receive treatment with medicinal plants, and about 90,000 insured people per year, use complementary medicine (CM) services in 83 CM care centers In addition, despite of being a multi-diverse country, no attention has been paid to the development of medicinal plants value chain, pointing out as some of the greatest challenges, the proper registration of these plants, the protection of their biodiversity, investment in research and the guarantee of quality and safety when being used [1]
In this report, based on the South American context, we approach the study of medicinal plants in Peruvian markets, in Cajamarca, describing collection and stockpiling of fresh and dried medicinal plants in two provinces capital, giving place to two informal value chains
The capital city (Cajamarca) is supplied with 470 medicinal species, most of them wild and native to the Andes. In this city there are various intermediaries in the market for medicinal plants, of which one of the most important is the stocker that supplies the markets of the Coast
Summary
In Peru 80% of the population uses phytotherapy as a medicinal resource, 76% of population insured by EsSalud (a health system for state employees) are willing to receive treatment with medicinal plants, and about 90,000 insured people per year, use complementary medicine (CM) services in 83 CM care centers In addition, despite of being a multi-diverse country, no attention has been paid to the development of medicinal plants value chain, pointing out as some of the greatest challenges, the proper registration of these plants, the protection of their biodiversity, investment in research and the guarantee of quality and safety when being used [1]. Cajamarca region’s land (Peru) is an important area for the collection, production, use and market of medicinal plants with pre-Inca heritage and is part of the Alternative Medicine - Update. In this report, based on the South American context, we approach the study of medicinal plants in Peruvian markets, in Cajamarca, describing collection and stockpiling of fresh and dried medicinal plants in two provinces capital, giving place to two informal value chains. The results of an observation on the collection of medicinal plants during the first months of the COVID-19 pandemic in these two markets are included
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
